ALC

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Alcon, Inc.

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Fribourg, Switzerland.
CEO
David J. Endicott
Employees
20000
Headquarters

rue Louis-d'Affry 6
http://www.alcon.com

News

Alcon Inc. (ALC): One of Oppenheimer’s Top Stock Picks For the Next 12 Months
Aug 27, 2024 22:42pm

We recently compiled a list of the Oppenheimer’s Favorite Stocks For Next 12 Months: Top 32 Stock Picks. In this article, we are going to take a look at where Alcon Inc. (NYSE:ALC) stands against Oppenheimer’s other favorite stocks for the next 12 months. The tail end of August is appearing to turn a fresh […]


Source:Insider Monkey
Earnings call: Alcon maintains steady growth with strategic investments
Aug 22, 2024 16:27pm

https://www.investing.com/news/stock-market-news/earnings-call-alcon-maintains-steady-growth-with-strategic-investments-93CH-3583744


Source:Investing.com
Alcon Analysts Increase Their Forecasts After Q2 Results
Aug 22, 2024 16:00pm

Alcon Inc. (NYSE: ALC ) reported mixed second-quarter results, after the closing bell on Tuesday. Alcon reported quarterly earnings of 74 cents per share which beat the analyst consensus estimate of 73 cents per share. The company reported quarterly sales of $2.48 billion which missed the analyst consensus estimate of $2.52 billion. “We are pleased with our solid second-quarter results, which were driven by robust demand for our innovative products, our balanced geographic footprint and strong execution by our team. These factors contributed to another quarter of sales and earnings growth and robust cash generation,” said David J. Endicott, Alcon’s Chief Executive Officer. “As we look to the second half of the … Full story available on Benzinga.com


Source:Benzinga
Alcon shares get a boost as Mizuho raises price target
Aug 22, 2024 11:09am

https://www.investing.com/news/company-news/alcon-shares-get-a-boost-as-mizuho-raises-price-target-93CH-3582941


Source:Investing.com
Alcon CEO says firm had ''very good'' revenue and underlying demand in the second quarter
Aug 22, 2024 09:25am

Alcon CEO David Endicott comments on the company''s second-quarter results.


Source:CNBC
Alcon Q2 Earnings Meet Estimates, Revenues Increase Y/Y
Aug 21, 2024 18:51pm

Alcon, Inc. (NYSE: ALC ) delivered core earnings per share of 74 cents in the second quarter of 2024, up 7.2% from the year-ago quarter''s figure (up 15% at the constant exchange rate or CER). The figure came in line with the Zacks Consensus Estimate. Alcon reports ‘core'' results based on non-IFRS (International Financial Reporting Standards) measures. In the second quarter, the company''s diluted EPS was 45 cents, up 32.4% year over year. Revenues in Detail Alcon''s net sales to third parties in the second quarter were $2.48 billion, which missed the Zacks Consensus Estimate by 1.4%. However, the top line increased by 3.3% from the year-ago quarter''s levels (up 6% at CER). Quarter in Detail Alcon reports operations through two segments — Surgical (comprising Implantables, Consumables and Equipment/Other) and Vision Care (comprising Contact Lenses and Ocular Health). Surgical In the second quarter of 2024, Surgical sales amounted to $1.42 billion, up 3% year over year and 6% at CER. Our model projected the segment''s growth to be 3.5% versus the prior year.


Source:Benzinga
Alcon Inc. (ALC) Q2 2024 Earnings Call Transcript
Aug 21, 2024 16:05pm

Alcon Inc. (NYSE:NYSE:ALC) Q2 2024 Earnings Conference Call August 21, 2024 8:00 AM ETCompany ParticipantsDan Cravens - Vice President, Investor…


Source:Seeking Alpha
Alcon shares drop on earnings miss
Aug 21, 2024 08:22am

https://www.investing.com/news/stock-market-news/alcon-shares-drop-on-earnings-miss-3580600


Source:Investing.com
Alcon stock poised for multi-year EPS growth, says Citi
Aug 21, 2024 07:24am

https://www.investing.com/news/company-news/alcon-stock-poised-for-multiyear-eps-growth-says-citi-93CH-3580549


Source:Investing.com
ALC Stock Earnings: Alcon Beats EPS, Misses Revenue for Q2 2024
Aug 21, 2024 02:53am

Alcon (NYSE: ALC ) just reported results for the second quarter of 2024. Alcon reported earnings per share of 74 cents. This was above the analyst estimate for EPS of 73 cents. The company reported revenue of $2.48 billion. This was 1.51% worse than the analyst estimate for revenue of $2.52 billion. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at [email protected]. More From InvestorPlace Legendary Investor Predicts: “Forget AI… THIS Technology Is the Future” The post ALC Stock Earnings: Alcon Beats EPS, Misses Revenue for Q2 2024 appeared first on InvestorPlace .


Source:InvestorPlace